KR20010023198A - 메틸셀룰로오스 정제를 신속히 분해시키는 방법 - Google Patents
메틸셀룰로오스 정제를 신속히 분해시키는 방법 Download PDFInfo
- Publication number
- KR20010023198A KR20010023198A KR1020007001826A KR20007001826A KR20010023198A KR 20010023198 A KR20010023198 A KR 20010023198A KR 1020007001826 A KR1020007001826 A KR 1020007001826A KR 20007001826 A KR20007001826 A KR 20007001826A KR 20010023198 A KR20010023198 A KR 20010023198A
- Authority
- KR
- South Korea
- Prior art keywords
- methylcellulose
- starch
- tablet according
- lauryl sulfate
- sodium lauryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229920000609 methyl cellulose Polymers 0.000 title claims abstract description 70
- 239000001923 methylcellulose Substances 0.000 title claims abstract description 66
- 239000000203 mixture Substances 0.000 claims abstract description 59
- 238000000034 method Methods 0.000 claims abstract description 14
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical group [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 68
- 235000010981 methylcellulose Nutrition 0.000 claims description 66
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 51
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 51
- 235000019359 magnesium stearate Nutrition 0.000 claims description 34
- 229920002472 Starch Polymers 0.000 claims description 27
- 229940032147 starch Drugs 0.000 claims description 27
- 235000019698 starch Nutrition 0.000 claims description 27
- 239000008107 starch Substances 0.000 claims description 27
- 239000003085 diluting agent Substances 0.000 claims description 22
- 229920002261 Corn starch Polymers 0.000 claims description 20
- 239000008120 corn starch Substances 0.000 claims description 20
- 239000002245 particle Substances 0.000 claims description 19
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical group C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 17
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 17
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 17
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 16
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 16
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 16
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 16
- 239000008187 granular material Substances 0.000 claims description 15
- 239000000314 lubricant Substances 0.000 claims description 11
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 8
- 239000008109 sodium starch glycolate Substances 0.000 claims description 8
- 229940079832 sodium starch glycolate Drugs 0.000 claims description 8
- 229920003109 sodium starch glycolate Polymers 0.000 claims description 8
- 239000007884 disintegrant Substances 0.000 claims description 7
- 239000000080 wetting agent Substances 0.000 claims description 7
- 229940099112 cornstarch Drugs 0.000 claims description 6
- 239000011230 binding agent Substances 0.000 claims description 5
- 239000003906 humectant Substances 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000007906 compression Methods 0.000 claims description 4
- 230000006835 compression Effects 0.000 claims description 4
- 229940057948 magnesium stearate Drugs 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229940069328 povidone Drugs 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 2
- 229960002900 methylcellulose Drugs 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 43
- 238000009472 formulation Methods 0.000 abstract description 30
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract description 26
- 230000015556 catabolic process Effects 0.000 abstract description 19
- 238000006731 degradation reaction Methods 0.000 abstract description 19
- 239000003826 tablet Substances 0.000 description 65
- 235000000346 sugar Nutrition 0.000 description 21
- 230000029087 digestion Effects 0.000 description 17
- 238000000354 decomposition reaction Methods 0.000 description 16
- 229920003084 Avicel® PH-102 Polymers 0.000 description 15
- 239000003086 colorant Substances 0.000 description 14
- 229920003086 cellulose ether Polymers 0.000 description 12
- 239000000975 dye Substances 0.000 description 12
- 150000008163 sugars Chemical class 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000011812 mixed powder Substances 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 229940023144 sodium glycolate Drugs 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- JEJAMASKDTUEBZ-UHFFFAOYSA-N tris(1,1,3-tribromo-2,2-dimethylpropyl) phosphate Chemical compound BrCC(C)(C)C(Br)(Br)OP(=O)(OC(Br)(Br)C(C)(C)CBr)OC(Br)(Br)C(C)(C)CBr JEJAMASKDTUEBZ-UHFFFAOYSA-N 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 229920003108 Methocel™ A4M Polymers 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- 230000002475 laxative effect Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 239000008141 laxative Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000007916 tablet composition Substances 0.000 description 3
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007894 caplet Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 229940105329 carboxymethylcellulose Drugs 0.000 description 2
- 229940081970 citrucel Drugs 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000001879 gelation Methods 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000007968 orange flavor Substances 0.000 description 2
- -1 siloids (SYLOID) Chemical compound 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 241001550224 Apha Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 235000015125 Sterculia urens Nutrition 0.000 description 1
- 240000001058 Sterculia urens Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 239000008380 degradant Substances 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000008202 granule composition Substances 0.000 description 1
- 238000009478 high shear granulation Methods 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000003230 hygroscopic agent Substances 0.000 description 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229940125722 laxative agent Drugs 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 229940037627 magnesium lauryl sulfate Drugs 0.000 description 1
- HBNDBUATLJAUQM-UHFFFAOYSA-L magnesium;dodecyl sulfate Chemical compound [Mg+2].CCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCOS([O-])(=O)=O HBNDBUATLJAUQM-UHFFFAOYSA-L 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5689997P | 1997-08-22 | 1997-08-22 | |
| US60/056,899 | 1997-08-22 | ||
| US8164498P | 1998-04-14 | 1998-04-14 | |
| US60/081,644 | 1998-04-14 | ||
| PCT/US1998/017440 WO1999009959A1 (en) | 1997-08-22 | 1998-08-21 | Rapidly disintegrating methylcellulose tablets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20010023198A true KR20010023198A (ko) | 2001-03-26 |
Family
ID=26735830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020007001826A Abandoned KR20010023198A (ko) | 1997-08-22 | 1998-08-21 | 메틸셀룰로오스 정제를 신속히 분해시키는 방법 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US6372253B1 (https=) |
| EP (1) | EP1014949A4 (https=) |
| JP (1) | JP2001513546A (https=) |
| KR (1) | KR20010023198A (https=) |
| CN (1) | CN1240374C (https=) |
| AR (3) | AR016827A1 (https=) |
| AU (1) | AU745682B2 (https=) |
| BR (1) | BR9811987A (https=) |
| CA (1) | CA2301132C (https=) |
| CO (1) | CO4960646A1 (https=) |
| EA (1) | EA003663B1 (https=) |
| HU (1) | HUP0003186A3 (https=) |
| MY (1) | MY137768A (https=) |
| NZ (1) | NZ502890A (https=) |
| PL (1) | PL338786A1 (https=) |
| TW (1) | TWI228421B (https=) |
| UA (1) | UA70926C2 (https=) |
| WO (1) | WO1999009959A1 (https=) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8071128B2 (en) * | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
| AR016827A1 (es) * | 1997-08-22 | 2001-08-01 | Smithkline Beecham Corp | PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA |
| AR017512A1 (es) * | 1997-08-22 | 2001-09-12 | Smithkline Beecham Corp | Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas |
| US6348264B1 (en) | 1998-04-27 | 2002-02-19 | Roquette Freres | Process for producing low de starch hydrolysates by nanofiltration fractionation, products obtained thereby, and use of such products |
| CA2342625A1 (en) * | 1998-09-08 | 2000-03-16 | Smithkline Beecham Corporation | Lipstatin derivative-soluble fiber tablets |
| ES2197064T3 (es) * | 2000-10-24 | 2004-01-01 | Fit Gmbh | Granulado de agentes de desintegracion conjuntamente elaborados. |
| IL156445A0 (en) * | 2001-01-26 | 2004-01-04 | Schering Corp | Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
| EP1574215B1 (en) | 2002-12-16 | 2015-07-15 | Kissei Pharmaceutical Co., Ltd. | Solid drug for oral use |
| US8367111B2 (en) * | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
| WO2005009395A2 (en) * | 2003-07-23 | 2005-02-03 | L. Perrigo Company | Cellulosic fiber containing composition |
| US7198653B2 (en) * | 2003-07-31 | 2007-04-03 | Delavau Llc | Calcium carbonate granulation |
| US7390503B1 (en) | 2003-08-22 | 2008-06-24 | Barr Laboratories, Inc. | Ondansetron orally disintegrating tablets |
| US8153161B2 (en) * | 2003-12-09 | 2012-04-10 | Dainippon Sumitomo Pharma Co., Ltd. | Medicament-containing particle and a solid preparation containing the particle |
| US8747895B2 (en) * | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
| US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
| NZ728442A (en) | 2004-10-21 | 2018-05-25 | Adare Pharmaceuticals Inc | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
| US20060105038A1 (en) * | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
| US7344907B2 (en) * | 2004-11-19 | 2008-03-18 | International Business Machines Corporation | Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale |
| PL1861427T3 (pl) * | 2005-03-23 | 2013-01-31 | Bpsi Holdings Llc | Kompozycje aglomerowanej skrobi |
| US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
| PT1885339E (pt) * | 2005-05-05 | 2015-10-12 | Bristol Myers Squibb Holdings Ireland | Formulações de um inibidor src/abl |
| PL1916995T5 (pl) * | 2005-07-29 | 2022-10-31 | Stichting Groningen Centre For Drug Research | Kontrolowany wartością ph impulsowy układ podawczy, sposoby przygotowania i zastosowanie |
| PE20070698A1 (es) * | 2005-11-14 | 2007-08-17 | Teijin Pharma Ltd | Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol |
| US9138414B1 (en) | 2006-09-15 | 2015-09-22 | Delavau Llc | Calcium supplement having enhanced absorption |
| PL2561766T3 (pl) | 2006-11-07 | 2018-06-29 | The Procter And Gamble Company | Kompozycje zawierające błonnik oraz sposoby ich wytwarzania i stosowania |
| EP2124901B1 (en) | 2007-02-01 | 2017-07-19 | Takeda Pharmaceutical Company Limited | Tablet preparation without causing a tableting trouble |
| US7767248B2 (en) * | 2007-02-02 | 2010-08-03 | Overly Iii Harry J | Soft chew confectionary with high fiber and sugar content and method for making same |
| CA2689434C (en) * | 2007-06-04 | 2017-09-26 | Shear/Kershman Laboratories, Inc. | Tamper resistant lipid-based oral dosage form for opioid agonists |
| US8420700B1 (en) * | 2008-06-04 | 2013-04-16 | James M. Bausch | Tamper resistant lipid-based oral dosage form for sympathomimetic amines |
| DE102008037324A1 (de) * | 2008-08-11 | 2010-02-18 | Ratiopharm Gmbh | Pharmazeutische Formulierung zur pulmonalen Blutdrucksenkung |
| KR20110097840A (ko) * | 2008-11-17 | 2011-08-31 | 바스프 에스이 | 전분 함유 과립 제제 |
| AU2010325746B2 (en) | 2009-12-02 | 2016-02-25 | Adare Pharmaceuticals S.R.L. | Fexofenadine microcapsules and compositions containing them |
| WO2011085181A1 (en) * | 2010-01-08 | 2011-07-14 | Eurand, Inc. | Taste masked topiramate composition and an orally disintegrating tablet comprising the same |
| TWI564008B (zh) | 2010-09-30 | 2017-01-01 | 鹽野義製藥股份有限公司 | 難溶性藥物之溶解性改善製劑 |
| WO2013060343A1 (en) * | 2011-10-25 | 2013-05-02 | Expermed S.A. | Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof |
| HUE043852T2 (hu) | 2012-07-27 | 2019-09-30 | Redhill Biopharma Ltd | A vastagbél kiürítésére szolgáló készítmények és a készítmények elõállítási módszerei |
| MX392941B (es) * | 2016-09-07 | 2025-03-24 | Celgene Corp | Composiciones para comprimidos. |
| MX2023003432A (es) | 2020-09-29 | 2023-08-04 | Millicent Pharma Ltd | Formulaciones orodispersables. |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3402240A (en) | 1957-06-25 | 1968-09-17 | Pfizer & Co C | Medicinal tablet and process of making same |
| US3039922A (en) | 1959-08-17 | 1962-06-19 | Carter Prod Inc | Method of administering tablets having decongestant and anti-histaminic activity |
| US3147187A (en) | 1962-09-10 | 1964-09-01 | Don Hall Lab | Sustained release pharmaceutical |
| US3622673A (en) | 1968-11-14 | 1971-11-23 | Upjohn Co | 4-(1,4,5,6-TETRAHYDROZEPINO 4,5-b INDOL-3(2H)-YL-BUTYROPHENON COMPOSITIONS AND PROCESS OF TREATMENT MENTAL OR EMOTIONAL DISORDERS |
| DE1931910B2 (de) | 1969-06-24 | 1974-11-28 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur Herstellung fester, steuerbar resorbierbarer Arzneimittelzubereitungen schwer löslicher Wirkstoffe |
| US3961056A (en) | 1974-02-11 | 1976-06-01 | The Upjohn Company | Substituted morpholine guanidines for the treatment of arrhythmic conditions |
| US3968211A (en) | 1974-02-11 | 1976-07-06 | The Upjohn Company | Compositions and methods of use of amidines for anti-arrhythmic purposes |
| JPS5438167B2 (https=) * | 1974-04-27 | 1979-11-19 | ||
| US4048331A (en) | 1974-10-15 | 1977-09-13 | The Upjohn Company | Process of treatment |
| US3969504A (en) | 1975-02-14 | 1976-07-13 | The Upjohn Co. | 6-Phenyl benzodiazepine antidepressants |
| US4148879A (en) | 1977-12-23 | 1979-04-10 | Nelson Research & Development Company | Inhibition of platelet aggregation with selected phosphonic and phosphinic acid esters |
| US4148878A (en) | 1977-12-23 | 1979-04-10 | Nelson Research & Development Company | Inhibition of platelet aggregation with selected phosphoric acid esters |
| US4327080A (en) | 1981-07-13 | 1982-04-27 | E. R. Squibb & Sons, Inc. | Novel Bendroflumethiazide formulations and method |
| JPS58144316A (ja) | 1982-02-18 | 1983-08-27 | Chiyoda Yakuhin Kk | 安定なインドメタシン錠 |
| US4508726A (en) | 1982-09-16 | 1985-04-02 | The Upjohn Company | Treatment of panic disorders with alprazolam |
| ZA841044B (en) | 1983-02-17 | 1984-09-26 | Merrell Dow Pharma | Dry mix cellulose ether compositions as bulk laxatives |
| US4517179A (en) | 1983-04-29 | 1985-05-14 | Pennwalt Corporation | Rapid dissolving, uniform drug compositions and their preparation |
| JPS6028915A (ja) | 1983-07-26 | 1985-02-14 | Eisai Co Ltd | ユビデカレノン高含量含有組成物 |
| US4476134A (en) | 1983-08-01 | 1984-10-09 | The Upjohn Company | Process for treating panic disorders |
| SE8601624D0 (sv) | 1986-04-11 | 1986-04-11 | Haessle Ab | New pharmaceutical preparations |
| IT1200178B (it) | 1986-07-23 | 1989-01-05 | Alfa Farmaceutici Spa | Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica |
| JPH0618774B2 (ja) | 1986-10-09 | 1994-03-16 | 塩野義製薬株式会社 | 糖衣錠の製造方法 |
| AU8325987A (en) | 1986-12-11 | 1988-06-30 | Upjohn Company, The | Antipsychotic amino-polyhydro-benz-(iso)quinolines and intermediates |
| JPS63222112A (ja) | 1987-03-10 | 1988-09-16 | Nippon Soda Co Ltd | 徐放性顆粒 |
| JPS63280023A (ja) | 1987-05-11 | 1988-11-17 | Yoshitomi Pharmaceut Ind Ltd | 抗リウマチ薬 |
| NO883326L (no) | 1987-08-11 | 1989-02-13 | Bayer Ag | Dhp-retard-tilberedning. |
| JPH01168619A (ja) | 1987-12-24 | 1989-07-04 | Takada Seiyaku Kk | 新規な酢酸クロルマジノン固形製剤 |
| US4866046A (en) | 1988-05-31 | 1989-09-12 | Top Laboratories, Inc. | Low-dosage sublingual aspirin |
| US5292520A (en) | 1990-09-13 | 1994-03-08 | Akzo N.V. | Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer |
| ATE113202T1 (de) | 1990-11-29 | 1994-11-15 | Wei Ming Pharmaceutical Mfg Co | Hilfsträger für direkte verpressung. |
| JPH0515319A (ja) | 1990-12-14 | 1993-01-26 | Sunstar Inc | 水難溶性塩類の分散法およびそれを分散してなる飲用組成物 |
| US5403593A (en) * | 1991-03-04 | 1995-04-04 | Sandoz Ltd. | Melt granulated compositions for preparing sustained release dosage forms |
| JPH05139973A (ja) | 1991-11-20 | 1993-06-08 | Shin Etsu Chem Co Ltd | ニフエジピン含有固形製剤の製造方法 |
| AU1193092A (en) | 1992-01-10 | 1993-08-03 | Obschestvo S Ogranichennoi Otvetstvennostju Meditsinsky Nauchno-Proizvodstvenny Komplex Biotiki | Granulated pharmaceutical composition and method of obtaining it |
| CA2135160A1 (en) * | 1992-05-08 | 1993-11-25 | Otsuka Pharmaceutical Factory, Inc. | Indole derivative |
| IT1255522B (it) | 1992-09-24 | 1995-11-09 | Ubaldo Conte | Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita' |
| DE4333190C2 (de) | 1993-09-29 | 1996-05-30 | Korsatko Werner Univ Prof Dr E | Zerbeißtablette mit verzögerter Wirkstoff-Freisetzung |
| US5496884A (en) | 1993-11-12 | 1996-03-05 | Lord Corporation | Aqueous adhesive for bonding elastomers |
| TW355683B (en) * | 1994-02-17 | 1999-04-11 | Janssen Pharmaceutica Nv | Composition containing micronized nebivolol |
| JPH07267850A (ja) | 1994-03-28 | 1995-10-17 | Eisai Co Ltd | 不快味を防止した医薬組成物及びその製造方法 |
| US5543099A (en) | 1994-09-29 | 1996-08-06 | Hallmark Pharmaceutical, Inc. | Process to manufacture micronized nifedipine granules for sustained release medicaments |
| GB9501127D0 (en) * | 1995-01-20 | 1995-03-08 | Wellcome Found | Tablet |
| AR017512A1 (es) | 1997-08-22 | 2001-09-12 | Smithkline Beecham Corp | Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas |
| AR016827A1 (es) * | 1997-08-22 | 2001-08-01 | Smithkline Beecham Corp | PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA |
-
1998
- 1998-08-18 AR ARP980104077A patent/AR016827A1/es unknown
- 1998-08-19 CO CO98047415A patent/CO4960646A1/es unknown
- 1998-08-20 MY MYPI98003810A patent/MY137768A/en unknown
- 1998-08-21 CA CA002301132A patent/CA2301132C/en not_active Expired - Fee Related
- 1998-08-21 HU HU0003186A patent/HUP0003186A3/hu unknown
- 1998-08-21 KR KR1020007001826A patent/KR20010023198A/ko not_active Abandoned
- 1998-08-21 BR BR9811987-7A patent/BR9811987A/pt not_active Application Discontinuation
- 1998-08-21 EA EA200000245A patent/EA003663B1/ru not_active IP Right Cessation
- 1998-08-21 TW TW087113822A patent/TWI228421B/zh not_active IP Right Cessation
- 1998-08-21 NZ NZ502890A patent/NZ502890A/en unknown
- 1998-08-21 UA UA2000020918A patent/UA70926C2/uk unknown
- 1998-08-21 CN CNB988102935A patent/CN1240374C/zh not_active Expired - Fee Related
- 1998-08-21 EP EP98943322A patent/EP1014949A4/en not_active Withdrawn
- 1998-08-21 US US09/485,625 patent/US6372253B1/en not_active Expired - Lifetime
- 1998-08-21 AU AU91146/98A patent/AU745682B2/en not_active Ceased
- 1998-08-21 PL PL98338786A patent/PL338786A1/xx not_active Application Discontinuation
- 1998-08-21 WO PCT/US1998/017440 patent/WO1999009959A1/en not_active Ceased
- 1998-08-21 JP JP2000507350A patent/JP2001513546A/ja active Pending
-
2002
- 2002-04-16 US US10/123,569 patent/US7132114B2/en not_active Expired - Lifetime
-
2005
- 2005-05-18 AR ARP050102043A patent/AR049055A2/es unknown
- 2005-05-19 AR ARP050102065A patent/AR049057A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2301132C (en) | 2007-11-13 |
| CN1240374C (zh) | 2006-02-08 |
| HUP0003186A2 (hu) | 2001-02-28 |
| UA70926C2 (uk) | 2004-11-15 |
| CO4960646A1 (es) | 2000-09-25 |
| HUP0003186A3 (en) | 2001-04-28 |
| AR049055A2 (es) | 2006-06-21 |
| AR016827A1 (es) | 2001-08-01 |
| AU9114698A (en) | 1999-03-16 |
| NZ502890A (en) | 2002-03-01 |
| US7132114B2 (en) | 2006-11-07 |
| CA2301132A1 (en) | 1999-03-04 |
| US6372253B1 (en) | 2002-04-16 |
| CN1276718A (zh) | 2000-12-13 |
| EP1014949A1 (en) | 2000-07-05 |
| PL338786A1 (en) | 2000-11-20 |
| AU745682B2 (en) | 2002-03-28 |
| AR049057A2 (es) | 2006-06-21 |
| BR9811987A (pt) | 2000-09-05 |
| EA003663B1 (ru) | 2003-08-28 |
| EA200000245A1 (ru) | 2000-08-28 |
| US20030049315A1 (en) | 2003-03-13 |
| WO1999009959A1 (en) | 1999-03-04 |
| MY137768A (en) | 2009-03-31 |
| JP2001513546A (ja) | 2001-09-04 |
| EP1014949A4 (en) | 2006-06-21 |
| TWI228421B (en) | 2005-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20010023198A (ko) | 메틸셀룰로오스 정제를 신속히 분해시키는 방법 | |
| KR100743767B1 (ko) | 신속히 붕해되는 메틸셀룰로오스 정제 | |
| AU779632B2 (en) | Rapidly disintegrating methylcellulose tablets | |
| AU2004237813B2 (en) | Rapidly disintegrating methylcellulose tablets | |
| CA2543223A1 (en) | Rapidly disintegrating methylcellulose tablets | |
| CA2550041A1 (en) | Rapidly disintegrating methylcellulose tablets | |
| MXPA00001857A (en) | Rapidly disintegrating methylcellulose tablets | |
| HUP0002703A2 (hu) | Gyorsan széteső metil-cellulóz tabletták | |
| MXPA00001856A (en) | Rapidly disintegrating methylcellulose tablets | |
| CZ2000631A3 (cs) | Tableta | |
| CN1981747A (zh) | 快速崩解的甲基纤维素片剂 | |
| CZ2000629A3 (cs) | Rychle se rozpadající tablety pro perorální podávání |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20000222 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| AMND | Amendment | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20030821 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20050530 Patent event code: PE09021S01D |
|
| AMND | Amendment | ||
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20060118 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20050530 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
| J201 | Request for trial against refusal decision | ||
| PJ0201 | Trial against decision of rejection |
Patent event date: 20060417 Comment text: Request for Trial against Decision on Refusal Patent event code: PJ02012R01D Patent event date: 20060118 Comment text: Decision to Refuse Application Patent event code: PJ02011S01I Appeal kind category: Appeal against decision to decline refusal Decision date: 20080318 Appeal identifier: 2006101003286 Request date: 20060417 |
|
| AMND | Amendment | ||
| PB0901 | Examination by re-examination before a trial |
Comment text: Amendment to Specification, etc. Patent event date: 20060517 Patent event code: PB09011R02I Comment text: Request for Trial against Decision on Refusal Patent event date: 20060417 Patent event code: PB09011R01I Comment text: Amendment to Specification, etc. Patent event date: 20050930 Patent event code: PB09011R02I Comment text: Amendment to Specification, etc. Patent event date: 20030821 Patent event code: PB09011R02I |
|
| B601 | Maintenance of original decision after re-examination before a trial | ||
| PB0601 | Maintenance of original decision after re-examination before a trial | ||
| J301 | Trial decision |
Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20060417 Effective date: 20080318 |
|
| PJ1301 | Trial decision |
Patent event code: PJ13011S01D Patent event date: 20070425 Comment text: Trial Decision on Objection to Decision on Refusal Appeal kind category: Appeal against decision to decline refusal Request date: 20060417 Decision date: 20080318 Appeal identifier: 2006101003286 |
|
| J2X1 | Appeal (before the patent court) |
Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL |
|
| PJ2001 | Appeal |
Patent event date: 20070425 Comment text: Trial Decision on Objection to Decision on Refusal Patent event code: PJ20011S01I Appeal kind category: Appeal against decision to decline refusal Decision date: 20080318 Appeal identifier: 2007201004519 Request date: 20070523 |
|
| J302 | Written judgement (patent court) |
Free format text: JUDGMENT (PATENT COURT) FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20070523 Effective date: 20080318 |
|
| PJ1302 | Judgment (patent court) |
Patent event date: 20080122 Comment text: Written Judgment (Patent Court) Patent event code: PJ13021S01D Request date: 20070523 Decision date: 20080318 Appeal identifier: 2007201004519 Appeal kind category: Appeal against decision to decline refusal |
|
| J2X2 | Appeal (before the supreme court) |
Free format text: APPEAL BEFORE THE SUPREME COURT FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL |
|
| PJ2002 | Appeal before the supreme court |
Comment text: Trial Decision on Objection to Decision on Refusal Patent event date: 20070425 Patent event code: PJ20021S01I Request date: 20080205 Appeal identifier: 2008301000552 Appeal kind category: Appeal against decision to decline refusal Decision date: 20080318 |
|
| PC1902 | Submission of document of abandonment before decision of registration | ||
| SUBM | Surrender of laid-open application requested | ||
| J121 | Written withdrawal of request for trial | ||
| PJ1201 | Withdrawal of trial |
Patent event code: PJ12011R01D Patent event date: 20080318 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2006101003286 Request date: 20060417 Appeal kind category: Appeal against decision to decline refusal Decision date: 20080318 |
|
| J123 | Written withdrawal of action (supreme court) | ||
| PJ1203 | Withdrawal of action (supreme court) |
Comment text: Written Withdrawal of Action Patent event code: PJ12031R01D Patent event date: 20080320 Appeal identifier: 2008301000552 Decision date: 20080318 Appeal kind category: Appeal against decision to decline refusal Request date: 20080205 |